InRetail brings drugstore division back to bond market

InRetail brings drugstore division back to bond market

Corporate & Sovereign Strategy Bonds Debt Fixed Income Andean Peru

InRetail Pharma, the pharmacy chain owned by Peruvian retail group InRetail, announced plans on Monday to issue new bonds to finance the buyback of all $400 million in outstanding 5.375% 2023 bonds. The Lima-based company, which does business under the brands Inkafarma and Mifarma, also asked bondholders to "eliminate restrictive covenants and certain events of default and reduce the minimum notice period required for optional redemptions of the notes to three days," it said in a securities fili

Already have an account?

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial